Joshua M. Zachariah - Partner

PDF Print Friendly Page
Joshua M. Zachariah

Download V-Card

San Francisco
Phone: +1 415-439-4310
Fax: +1 415-439-1500
Overview News Publications

Professional Profile

Joshua Zachariah’s practice focuses on mergers and acquisitions, corporate finance, securities and general corporate matters. He has represented public and private acquirers and target companies in a variety of domestic and cross-border acquisition and disposition transactions, joint ventures and other corporate transactions.

Representative Matters

  • Vista Equity Partners in numerous transactions, including its:

    • $1.9 billion sale of Websense, Inc. to Raytheon Company;

    • $4.3 billion acquisition of TIBCO Software;

    • $178 million acquisition of XRS Corporation;

    • $644 million acquisition of Greenway Medical Technologies; and

    • $1.0 billion acquisition of Websense, Inc.

  • Bristol-Myers Squibb in numerous transactions, including its:

    • $2.1 billion acquisition of Cardioxyl Pharmaceuticals, including milestones;

    • $444 million acquisition of Galecto Biotech AB, including milestones;

    • $475 million acquisition of F-star Alpha Ltd., including milestones;

    • $4.3 billion sale to AstraZeneca of its interest in the companies’ diabetes alliance;

    • $7 billion acquisition of Amylin Pharmaceuticals and joint collaboration with AstraZeneca plc;

    • $2.5 billion acquisition of Inhibitex; and

    • $885 million acquisition of Zymogenetics.

  • Citigroup as financial advisor to:

    • Beacon Roofing Supply in their $1.1 billion acquisition of Roofing Supply Group; and

    • Ceradyne in its $860 million sale to 3M.

  • Centerview as financial advisor to Activision Blizzard in its $8.2 billion repurchase of shares from Vivendi.

  • Akorn, Inc. in its:

    • $440 million acquisition of VPI Holdings Corp., the parent company of VersaPharm Incorporated; and

    • $640 million acquisition of Hi-Tech Pharmacal.

  • Duff & Phelps Corporation in its $665 million acquisition by a private equity consortium led by The Carlyle Group.

  • Alcoa in its $27 billion proposed unsolicited acquisition of Alcan.

  • Realogy in its:

    • sale to Apollo for $9 billion; and

    • $740 million self tender offer for common stock.

  • Travelport in its sale to Blackstone for $4.3 billion.

  • Danaher in its $500 million acquisition of X-Rite.

  • Golden Gate Capital in its $470 million acquisition of California Pizza Kitchen.

  • Vestar Capital in its $294 million acquisition of Healthgrades.

  • ING in the sale of its $270 million reinsurance business.

  • Greenfield Partners in its $165 million acquisition of Clayton Holdings.

  • McCormick & Schmick’s Seafood Restaurants including:

    • in connection with an unsolicited acquisition proposal from Landry’s; and

    • its sale to Landry’s for $131 million.

  • Caris Diagnostics in numerous acquisitions, including its $40 million acquisition of a molecular profiling company.

  • Healthsouth in a series of recapitalization transactions, including the company's $2 billion debt tender offer, $1 billion high-yield notes offering and $400 million private placement of preferred stock.

  • Cendant in its:

    • $2.6 billion debt tender offer; and

    • separation into four separate companies.

  • Warnaco in various corporate matters, including the transfer of its listing to the NYSE and the sale of a division to an Italian apparel company.

Memberships & Affiliations

Member of the South Asian Bar Association of Northern California

Other Distinctions

Adjunct Professor, New York University School of Law, "Negotiating Corporate Transactions," 2013-2014

Prior Experience

Skadden, Arps, Slate, Meagher & Flom LLP, 2005-2010

© 2015 Kirkland & Ellis LLP